ArticleJournal of clinical medicine2022

Targeting CD38 with Daratumumab Plus Chemotherapy for Patients with Advanced-Stage Plasmablastoid Large B-Cell Lymphoma.

Yun Kyoung Ryu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.